- Home
- ASIX vs ARVN Comparison
ASIX vs ARVN Comparison
Compare ASIX & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASIX
- ARVN
- Stock Information
- Founded
- ASIX 2016
- ARVN 2015
- Country
- ASIX United States
- ARVN United States
- Employees
- ASIX N/A
- ARVN N/A
- Industry
- ASIX Major Chemicals
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- ASIX Industrials
- ARVN Health Care
- Exchange
- ASIX Nasdaq
- ARVN Nasdaq
- Market Cap
- ASIX 561.0M
- ARVN 456.2M
- IPO Year
- ASIX N/A
- ARVN 2018
- Fundamental
- Price
- ASIX $21.46
- ARVN $7.73
- Analyst Decision
- ASIX Buy
- ARVN Buy
- Analyst Count
- ASIX 1
- ARVN 22
- Target Price
- ASIX $32.00
- ARVN $20.21
- AVG Volume (30 Days)
- ASIX 235.8K
- ARVN 1.9M
- Earning Date
- ASIX 10-31-2025
- ARVN 10-29-2025
- Dividend Yield
- ASIX 2.98%
- ARVN N/A
- EPS Growth
- ASIX 829.30
- ARVN N/A
- EPS
- ASIX 2.84
- ARVN N/A
- Revenue
- ASIX $1,515,062,000.00
- ARVN $372,800,000.00
- Revenue This Year
- ASIX $7.41
- ARVN $4.87
- Revenue Next Year
- ASIX $4.60
- ARVN N/A
- P/E Ratio
- ASIX $7.56
- ARVN N/A
- Revenue Growth
- ASIX 1.31
- ARVN 299.57
- 52 Week Low
- ASIX $17.97
- ARVN $5.90
- 52 Week High
- ASIX $33.00
- ARVN $29.61
- Technical
- Relative Strength Index (RSI)
- ASIX 58.26
- ARVN 57.63
- Support Level
- ASIX $20.38
- ARVN $6.96
- Resistance Level
- ASIX $21.11
- ARVN $8.22
- Average True Range (ATR)
- ASIX 0.63
- ARVN 0.33
- MACD
- ASIX 0.34
- ARVN 0.11
- Stochastic Oscillator
- ASIX 99.57
- ARVN 72.47
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.